MYNZ
Price
$1.77
Change
+$0.08 (+4.73%)
Updated
Aug 15 closing price
Capitalization
8.1M
18 days until earnings call
STSS
Price
$4.97
Change
-$0.15 (-2.93%)
Updated
Aug 15 closing price
Capitalization
5.09M
Interact to see
Advertisement

MYNZ vs STSS

Header iconMYNZ vs STSS Comparison
Open Charts MYNZ vs STSSBanner chart's image
Mainz Biomed
Price$1.77
Change+$0.08 (+4.73%)
Volume$137.18K
Capitalization8.1M
Sharps Technology
Price$4.97
Change-$0.15 (-2.93%)
Volume$45.47K
Capitalization5.09M
MYNZ vs STSS Comparison Chart in %
Loading...
MYNZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MYNZ vs. STSS commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MYNZ is a Hold and STSS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (MYNZ: $1.77 vs. STSS: $4.97)
Brand notoriety: MYNZ and STSS are both not notable
MYNZ represents the Medical Specialties, while STSS is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: MYNZ: 76% vs. STSS: 44%
Market capitalization -- MYNZ: $8.1M vs. STSS: $5.09M
MYNZ [@Medical Specialties] is valued at $8.1M. STSS’s [@Pharmaceuticals: Other] market capitalization is $5.09M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $172.16B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.48B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MYNZ’s FA Score shows that 1 FA rating(s) are green whileSTSS’s FA Score has 0 green FA rating(s).

  • MYNZ’s FA Score: 1 green, 4 red.
  • STSS’s FA Score: 0 green, 5 red.
According to our system of comparison, STSS is a better buy in the long-term than MYNZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MYNZ’s TA Score shows that 7 TA indicator(s) are bullish while STSS’s TA Score has 7 bullish TA indicator(s).

  • MYNZ’s TA Score: 7 bullish, 3 bearish.
  • STSS’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, both MYNZ and STSS are a good buy in the short-term.

Price Growth

MYNZ (@Medical Specialties) experienced а +23.78% price change this week, while STSS (@Pharmaceuticals: Other) price change was -23.54% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.75%. For the same industry, the average monthly price growth was +4.85%, and the average quarterly price growth was +1.62%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.53%. For the same industry, the average monthly price growth was -0.29%, and the average quarterly price growth was +4.24%.

Reported Earning Dates

MYNZ is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Medical Specialties (+3.75% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (+0.53% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MYNZ($8.1M) has a higher market cap than STSS($5.09M). MYNZ YTD gains are higher at: -59.028 vs. STSS (-99.196). STSS has higher annual earnings (EBITDA): -9.1M vs. MYNZ (-20.22M). STSS has more cash in the bank: 11.9M vs. MYNZ (978K). STSS has less debt than MYNZ: STSS (2.33M) vs MYNZ (8.27M). MYNZ has higher revenues than STSS: MYNZ (917K) vs STSS (0).
MYNZSTSSMYNZ / STSS
Capitalization8.1M5.09M159%
EBITDA-20.22M-9.1M222%
Gain YTD-59.028-99.19660%
P/E RatioN/AN/A-
Revenue917K0-
Total Cash978K11.9M8%
Total Debt8.27M2.33M354%
TECHNICAL ANALYSIS
Technical Analysis
MYNZSTSS
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
78%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
MYNZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LUCD1.020.04
+3.96%
Lucid Diagnostics
DFH28.00-0.04
-0.14%
Dream Finders Homes
KXIN0.70N/A
-0.19%
Kaixin Holdings
PFG77.64-0.45
-0.58%
Principal Financial Group
ALRS21.60-0.41
-1.86%
Alerus Financial Corp

MYNZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, MYNZ has been loosely correlated with ACRS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MYNZ jumps, then ACRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYNZ
1D Price
Change %
MYNZ100%
+4.73%
ACRS - MYNZ
41%
Loosely correlated
+10.65%
PLLWF - MYNZ
28%
Poorly correlated
N/A
OPK - MYNZ
27%
Poorly correlated
+1.48%
STXS - MYNZ
27%
Poorly correlated
-5.86%
GH - MYNZ
24%
Poorly correlated
-2.45%
More